Trevena Inc. buy melinda
Start price
21.11.17
/
50%
€42.17
Target price
19.12.17
€58.63
Performance (%)
-14.71%
End price
19.12.17
€35.97
Summary
This prediction ended on 19.12.17 with a price of €35.97. The prediction for Trevena Inc. disappointed with a performance of -14.71%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Trevena Inc. | - | - | - | - |
| iShares Core DAX® | 0.794% | 2.841% | 22.630% | 72.985% |
| iShares Nasdaq 100 | 0.016% | -0.939% | 6.943% | 115.777% |
| iShares Nikkei 225® | 0.309% | -0.648% | 13.619% | 49.561% |
| iShares S&P 500 | 0.181% | -0.442% | 4.692% | 69.577% |
Comments by melinda for this prediction
In the thread Trevena Inc. diskutieren
Trevena, Inc. ist ein biopharmazeutisches company.It entdeckt, entwickelt
(Vom Mitglied beendet)


